Abstract
Polycystic ovarian syndrome (PCOS) is a common heterogeneous, multifactorial and chronic endocrine disorder characterized by multiple hormonal imbalances, occupied by manifestations of hyperandrogenism and many a times with hyperthyroidism. Clomiphene is a well known drug for its safety, effectiveness and relatively low cost as compared to other drugs. The aim of the present study is to evaluate the effect of clomiphene on anthropometry measurement and thyroxine hormones in Iraqi women. Seventy three infertile patients with polycystic ovary syndrome (PCOS) were enrolled in the present study. They were randomly divided into three groups. Three doses of clomiphine (50, 100 and 150mg) were given to enrolled patients (n=72). Lower concentration of clomiphene showed decreases in the body mass index and waist-hip ratio of obese and overweight individuals. Lower dose (50mg) of the clomiphene is effective while higher dose (100 and 150mg) showed non-significant increase in the serum T3 level. The present study concluded that clomiphene act effectively on the obesity and patients treated with this showed a positive effect.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Public Health Research & Development
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
